Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 07 Dec 2023

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study

in Hematologic Malignancies

Anna Cardellino
Julia R. Correll
Mona Martin
Boris Gorsh
Sandhya Sapra
Rakesh Popat

Frontiers in Oncology

doi 10.3389/fonc.2023.1274659

2,289 views
1 citation

Review

Published on 06 Dec 2023

Deep learning enhances acute lymphoblastic leukemia diagnosis and classification using bone marrow images

in Hematologic Malignancies

Basel Elsayed
Mohamed Elhadary
Raghad Mohamed Elshoeibi
Amgad Mohamed Elshoeibi
Ahmed Badr
Omar Metwally
Raghad Alaa ElSherif
Mohamed Elsayed Salem
Fatima Khadadah
Awni Alshurafa

Frontiers in Oncology

doi 10.3389/fonc.2023.1330977

5,150 views
12 citations

Brief Research Report

Published on 06 Dec 2023

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma

in Hematologic Malignancies

Angélique Bruyer
Laure Dutrieux
Hugues de Boussac
Thibaut Martin
Djamila Chemlal
Nicolas Robert
Guilhem Requirand
Guillaume Cartron
Laure Vincent
Charles Herbaux

Frontiers in Oncology

doi 10.3389/fonc.2023.1271847

2,576 views
5 citations

Review

Published on 06 Dec 2023

Molecular mechanisms of ferroptosis and its roles in leukemia

in Hematologic Malignancies

Zhe Chen
Suying Zheng
Jiongping Han
Leihua Fu
Jiaping Fu
Zhijian Zhang
Pan Hong
Weiying Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1308869

3,281 views
2 citations

Original Research

Published on 04 Dec 2023

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

in Hematologic Malignancies

Baustin M. Welch
Bryce A. Manso
Kimberly A. Gwin
Petra K. Lothert
Sameer A. Parikh
Neil E. Kay
Kay L. Medina

Frontiers in Oncology

doi 10.3389/fonc.2023.1302038

2,070 views

Original Research

Published on 04 Dec 2023

Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia

in Hematologic Malignancies

Meidan Hou
Yanan Huang
Jinsong Yan
Guoguang Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1277978

1,348 views
2 citations

Editorial

Published on 01 Dec 2023

Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

in Hematologic Malignancies

Luca Lo Nigro

Frontiers in Oncology

doi 10.3389/fonc.2023.1293795

860 views

Original Research

Published on 01 Dec 2023

Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers

in Hematologic Malignancies

Maria Perpétuo Socorro Sampaio Carvalho
Fábio Magalhães-Gama
Bruna Pires Loiola
Juliana Costa Ferreira Neves
Nilberto Dias Araújo
Flavio Souza Silva
Claudio Lucas Santos Catão
Eliana Brasil Alves
João Paulo Diniz Pimentel
Maria Nazaré Saunier Barbosa

Frontiers in Oncology

doi 10.3389/fonc.2023.1290505

4,095 views
1 citation

Case Report

Published on 01 Dec 2023

Case Report: Identification of a novel LYN::LINC01900 transcript with promyelocytic phenotype and TP53 mutation in acute myeloid leukemia

in Hematologic Malignancies

Chengjun Hu
Qiuxin Dai
Ruiyi Zhang
Huanping Yang
Man Wang
Kaili Gu
Jiangang Yang
Wenjun Meng
Ping Chen
Maozhong Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1322403

3,569 views

Original Research

Published on 30 Nov 2023

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities

in Hematologic Malignancies

Yi Chen
Jing Zheng
Yanyan Qiu
Zhengjun Wu
Xiaofeng Luo
Liangfang Zhu
Yong Wu
Yanjuan Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1294037

1,844 views

Original Research

Published on 30 Nov 2023

Patient-reported symptoms and diagnostic journey in Multiple Myeloma

in Hematologic Malignancies

Rohit Vijjhalwar
Kaiyang Song
Roshi Shrestha
Stella Bowcock
Maria T. Sanchez-Santos
Karthik Ramasamy
Muhammad Kassim Javaid

Frontiers in Oncology

doi 10.3389/fonc.2023.1282569

3,025 views
2 citations

Original Research

Published on 30 Nov 2023

Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia

in Hematologic Malignancies

Peng Ke
Jundan Xie
Ting Xu
Meiyu Chen
Yusha Guo
Ying Wang
Huiying Qiu
Depei Wu
Zhao Zeng
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1302356

2,962 views
2 citations

Case Report

Published on 30 Nov 2023

Treatment for a primary multidrug-resistant B-cell acute lymphoblastic leukemia patient carrying a SSBP2-CSF1R fusion gene: a case report

in Hematologic Malignancies

Huan Wang
Yujiao Wang
Liangchun Hao
Xuan Liu
Jihong Zhang
Pin Yao
Danping Liu
Runan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1291570

1,800 views

Case Report

Published on 28 Nov 2023

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review

in Hematologic Malignancies

Jiajie He
Rui Zou
Liqing Kang
Lingzi Yu
Peng Wang
Yang Shao
Junheng Liang
Depei Wu
Zhengming Jin
Changju Qu

Frontiers in Oncology

doi 10.3389/fonc.2023.1283194

2,222 views

Original Research

Published on 28 Nov 2023

Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes

in Hematologic Malignancies

Mohammad Ma’koseh
Heba Farfoura
Yumna Khatib
Zaid Omari
Hazim Ababneh
Baha A. Fayoumi
Ayat Taqash
Mohammad Al-Rwashdeh
Alaa Abufara
Omar Shahin

Frontiers in Oncology

doi 10.3389/fonc.2023.1063438

4,224 views
1 citation

Original Research

Published on 27 Nov 2023

Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

in Hematologic Malignancies

Lingling Wang
Conglin Xi
Yongfen Huang
Hao Xu
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1280033

1,313 views